Jóri, B.; Schatz, S.; Kaller, L.; Kah, B.; Roeper, J.; Ramdani, H.O.; Diehl, L.; Hoffknecht, P.; Grohé, C.; Griesinger, F.;
et al. Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. Cancers 2021, 13, 2861.
https://doi.org/10.3390/cancers13122861
AMA Style
Jóri B, Schatz S, Kaller L, Kah B, Roeper J, Ramdani HO, Diehl L, Hoffknecht P, Grohé C, Griesinger F,
et al. Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. Cancers. 2021; 13(12):2861.
https://doi.org/10.3390/cancers13122861
Chicago/Turabian Style
Jóri, Balázs, Stefanie Schatz, Len Kaller, Bettina Kah, Julia Roeper, Hayat O. Ramdani, Linda Diehl, Petra Hoffknecht, Christian Grohé, Frank Griesinger,
and et al. 2021. "Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy" Cancers 13, no. 12: 2861.
https://doi.org/10.3390/cancers13122861
APA Style
Jóri, B., Schatz, S., Kaller, L., Kah, B., Roeper, J., Ramdani, H. O., Diehl, L., Hoffknecht, P., Grohé, C., Griesinger, F., Tiemann, M., Heukamp, L. C., & Falk, M.
(2021). Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. Cancers, 13(12), 2861.
https://doi.org/10.3390/cancers13122861